P
Pacira BioSciences D
D
PCRX
24.270
USD
-0.19
(-0.78%)
مغلق
حجم التداول
23,664
الربح لكل سهم
3
العائد الربحي
-
P/E
-11
حجم السوق
1,123,814,268
الأخبار المقالات
العنوان: Pacira BioSciences
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.